'' Cell IDx

Human Immune Subsets Panels Gallery

Astrocytoma: CD8, FoxP3, PD-1, CD4

CD8, FoxP3, PD-1, CD4

Astrocytoma

Astrocytoma: CD8, FoxP3, PD-1, CD4 20x

CD8, FoxP3, PD-1, CD4 20x

Astrocytoma

Bladder Transitional Cell Carcinoma: CD163, PD-L1, PanCK, CD68

CD163, PD-L1, PanCK, CD68

Bladder Transitional Cell Carcinoma

Bladder Transitional Cell Carcinoma: CD163, PD-L1, PanCK, CD68 20x

CD163, PD-L1, PanCK, CD68 20x

Bladder Transitional Cell Carcinoma

Bladder Transitional Cell Carcinoma: CD8, PD-L1, PanCK, CD68

CD8, PD-L1, PanCK, CD68

Bladder Transitional Cell Carcinoma

Bladder Transitional Cell Carcinoma: CD8, PD-L1, PanCK, CD68 20x

CD8, PD-L1, PanCK, CD68 20x

Bladder Transitional Cell Carcinoma

Bladder Transitional Cell Carcinoma: CD3, CD4, CD8, CD20

CD3, CD4, CD8, CD20

Bladder Transitional Cell Carcinoma

Bladder Transitional Cell Carcinoma: CD3, CD4, CD8, CD20 20x

CD3, CD4, CD8, CD20 20x

Bladder Transitional Cell Carcinoma

Breast Invasive Ductal Carcinoma: CD8, FoxP3, PD-1, CD4

CD8, FoxP3, PD-1, CD4

Breast Invasive Ductal Carcinoma

Breast Invasive Ductal Carcinoma: CD8, FoxP3, PD-1, CD4 20x

CD8, FoxP3, PD-1, CD4 20x

Breast Invasive Ductal Carcinoma

Breast Invasive Ductal Carcinoma: CD8, PD-L1, PanCK, CD68

CD8, PD-L1, PanCK, CD68

Breast Invasive Ductal Carcinoma

Breast Invasive Ductal Carcinoma: CD8, PD-L1, PanCK, CD68 15x

CD8, PD-L1, PanCK, CD68 15x

Breast Invasive Ductal Carcinoma

Esophageal Squamous Cell Carcinoma: CD163, PD-L1, PanCK, CD68

CD163, PD-L1, PanCK, CD68

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma: CD163, PD-L1, PanCK, CD68 20x

CD163, PD-L1, PanCK, CD68 20x

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma: CD163, PD-L1, PanCK, CD68 20x. ROI-2.

CD163, PD-L1, PanCK, CD68 20x

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma: CD8, PD-L1, PD-1, CD68

CD8, PD-L1, PD-1, CD68

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma: CD8, PD-L1, PD-1, CD68 20x

CD8, PD-L1, PD-1, CD68 20x

Esophageal Squamous Cell Carcinoma

Head & Neck Nasopharyngeal Carcinoma: CD163, PD-L1, PanCK, CD68

CD163, PD-L1, PanCK, CD68

Head & Neck Nasopharyngeal Carcinoma

Head & Neck Nasopharyngeal Carcinoma: CD163, PD-L1, PanCK, CD68 20x

CD163, PD-L1, PanCK, CD68 20x

Head & Neck Nasopharyngeal Carcinoma

Head & Neck Nasopharyngeal Carcinoma: CD3, CD4, CD8, CD20

CD3, CD4, CD8, CD20

Head & Neck Nasopharyngeal Carcinoma

Head & Neck Nasopharyngeal Carcinoma: CD3, CD4, CD8, CD20 20x

CD3, CD4, CD8, CD20 20x

Head & Neck Nasopharyngeal Carcinoma

Head & Neck Squamous Cell Carcinoma: PanCK, PD-L1, CD68, CD163 (1). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PanCK, PD-L1, CD68, CD163 (1)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PanCK, PD-L1, CD68, CD163 (2). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PanCK, PD-L1, CD68, CD163 (2)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PanCK, PD-L1, CD68, CD163 (3). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PanCK, PD-L1, CD68, CD163 (3)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PanCK, PD-L1, CD68, CD163 (4). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PanCK, PD-L1, CD68, CD163 (4)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PanCK, PD-L1, CD68, CD163 (5). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PanCK, PD-L1, CD68, CD163 (5)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PD-L1, CD163. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PD-L1, CD163

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PD-L1, CD68, CD163. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PD-L1, CD68, CD163

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: PD-L1, CD68. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

PD-L1, CD68

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD8, PD-1. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD8, PD-1

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, PD-1. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, PD-1

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, FoxP3. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, FoxP3

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, CD8, FoxP3, PD-1. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, CD8, FoxP3, PD-1

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, CD8, CD20, FoxP3 (1). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, CD8, CD20, FoxP3 (1)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, CD8, CD20, FoxP3 (2). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, CD8, CD20, FoxP3 (2)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, CD8, CD20, FoxP3 (3). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, CD8, CD20, FoxP3 (3)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, CD8, CD20, FoxP3 (4). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, CD8, CD20, FoxP3 (4)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD4, CD8, CD20, FoxP3 (5). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD4, CD8, CD20, FoxP3 (5)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: CD8, CD68, PD-1, PD-L1. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

CD8, CD68, PD-1, PD-L1

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: HPV-, CD3, CD4, CD8, CD20 (1). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

HPV-, CD3, CD4, CD8, CD20 (1)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: HPV-, CD3, CD4, CD8, CD20 (2). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

HPV-, CD3, CD4, CD8, CD20 (2)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: HPV-, CD3, CD4, CD8, CD20 (3). Tissue courtesy of Dr. Mark Lingen, University of Chicago.

HPV-, CD3, CD4, CD8, CD20 (3)

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: HPV+, CD3, CD4, CD8, CD20. 2-panel overlay, Tissue courtesy of Dr. Mark Lingen, University of Chicago.

HPV+, CD3, CD4, CD8, CD20

Head & Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma: HPV+, CD3, CD4, CD8, CD20. Tissue courtesy of Dr. Mark Lingen, University of Chicago.

HPV+, CD3, CD4, CD8, CD20

Head & Neck Squamous Cell Carcinoma

Hodgkin’s Lymphoma: CD8, PD-L1, PD-1, CD68

CD8, PD-L1, PD-1, CD68

Hodgkin’s Lymphoma

Hodgkin’s Lymphoma: CD8, PD-L1, PD-1, CD68 20x

CD8, PD-L1, PD-1, CD68 20x

Hodgkin’s Lymphoma

Hodgkin’s Lymphoma: CD3, CD4, CD8, CD20

CD3, CD4, CD8, CD20

Hodgkin’s Lymphoma

Hodgkin’s Lymphoma: CD3, CD4, CD8, CD20 10x

CD3, CD4, CD8, CD20 10x

Hodgkin’s Lymphoma

Hodgkin’s Lymphoma: CD3, CD4, CD8, CD20 20x

CD3, CD4, CD8, CD20 20x

Hodgkin’s Lymphoma

Human Tonsil: CD4, CD8, FoxP3, Tbet

CD4, CD8, FoxP3, Tbet

Human Tonsil

Human Tonsil: CD68, CD8, CD56, GranzymeB

CD68, CD8, CD56, GranzymeB

Human Tonsil

Human Tonsil: Ki-67, CD8, CD4, CD31 5x

Ki-67, CD8, CD4, CD31 5x

Human Tonsil

Human Tonsil: Ki-67, CD8, CD4, CD31 20x

Ki-67, CD8, CD4, CD31 20x

Human Tonsil

Human Tonsil: CD4, CD8, CD20, CD68

CD4, CD8, CD20, CD68

Human Tonsil

Human Tonsil: PD-1, PD-L1, CD8, CD68

PD-1, PD-L1, CD8, CD68

Human Tonsil

Human Tonsil: PDL1, IDO, CD163, CD68 (1)

PDL1, IDO, CD163, CD68 (1)

Human Tonsil

Human Tonsil: PDL1, IDO, CD163, CD68 (2)

PDL1, IDO, CD163, CD68 (2)

Human Tonsil

Intestine, Rectum – Adenocarcinoma: CD8, FoxP3, PD-1, CD4

CD8, FoxP3, PD-1, CD4

Intestine, Rectum – Adenocarcinoma

Intestine, Rectum – Adenocarcinoma: CD8, FoxP3, PD-1, CD4 20x

CD8, FoxP3, PD-1, CD4 20x

Intestine, Rectum – Adenocarcinoma

Intestine, Rectum – Adenocarcinoma: CD8, FoxP3, Tbet, CD4

CD8, FoxP3, Tbet, CD4

Intestine, Rectum – Adenocarcinoma

Intestine, Rectum – Adenocarcinoma: CD8, FoxP3, Tbet, CD4 20x

CD8, FoxP3, Tbet, CD4 20x

Intestine, Rectum – Adenocarcinoma

Intestine, Rectum – Adenocarcinoma: CD8, FoxP3, Tbet, CD4 20x. ROI-2.

CD8, FoxP3, Tbet, CD4 20x

Intestine, Rectum – Adenocarcinoma

Luminal B Breast Cancer: CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)

Luminal B Breast Cancer

Luminal B Breast Cancer: CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)

Luminal B Breast Cancer

Luminal B Breast Cancer: CD4, CD8, FoxP3, Tbet

CD4, CD8, FoxP3, Tbet

Luminal B Breast Cancer

Lung Cancer: CD68, CD163, PanCK, PD-L1. Tissue courtesy of Dr. Jair Bar, Sheba Medical Center.

CD68, CD163, PanCK, PD-L1

Lung Cancer

Lung Cancer: CD3, CD4, CD8, CD20. Tissue courtesy of Dr. Jair Bar, Sheba Medical Center.

CD3, CD4, CD8, CD20

Lung Cancer

Lymph Node – Anaplastic Large Cell Lymphoma: CD8, FoxP3, CD3, CD4

CD8, FoxP3, CD3, CD4

Lymph Node – Anaplastic Large Cell Lymphoma

Lymph Node – Anaplastic Large Cell Lymphoma: CD8, FoxP3, CD3, CD4 20x

CD8, FoxP3, CD3, CD4 20x

Lymph Node – Anaplastic Large Cell Lymphoma

Lymph Node – Anaplastic Large Cell Lymphoma: CD8, FoxP3, CD3, CD4 20x. ROI-2.

CD8, FoxP3, CD3, CD4 20x

Lymph Node – Anaplastic Large Cell Lymphoma

Lymph Node – Anaplastic Large Cell Lymphoma: CD8, PD-L1, PD-1, CD68

CD8, PD-L1, PD-1, CD68

Lymph Node – Anaplastic Large Cell Lymphoma

Lymph Node – Anaplastic Large Cell Lymphoma: CD8, PD-L1, PD-1, CD68 20x

CD8, PD-L1, PD-1, CD68 20x

Lymph Node – Anaplastic Large Cell Lymphoma

Melanoma: CD4, CD8, FoxP3, Tbet

CD4, CD8, FoxP3, Tbet

Melanoma

Ovary – Endometrioid Adenocarcinoma: CD8, FoxP3, CD3, CD4

CD8, FoxP3, CD3, CD4

Ovary – Endometrioid Adenocarcinoma

Ovary – Endometrioid Adenocarcinoma: CD8, FoxP3, CD3, CD4 20x

CD8, FoxP3, CD3, CD4 20x

Ovary – Endometrioid Adenocarcinoma

Ovary – Endometrioid Adenocarcinoma: CD8, FoxP3, CD3, CD4 20x. ROI-2.

CD8, FoxP3, CD3, CD4 20x

Ovary – Endometrioid Adenocarcinoma

Pancreatic Ductal Adenocarcinoma: CD3, CD4, CD8, FoxP3

CD3, CD4, CD8, FoxP3

Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma: CD20, CD68, PD-1, PD-L1

CD20, CD68, PD-1, PD-L1

Pancreatic Ductal Adenocarcinoma

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD68, FoxP3, PD-1. 2-panel overlay.

CD3, CD4, CD8, CD68, FoxP3, PD-1

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD20 (1)

CD3, CD4, CD8, CD20 (1)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD20 (2)

CD3, CD4, CD8, CD20 (2)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD20 (3)

CD3, CD4, CD8, CD20 (3)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, CD4, CD8, CD20 (1)

CD3, CD4, CD8, CD20 (1)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD8, FoxP3, PD-1, PD-L1 (1)

CD8, FoxP3, PD-1, PD-L1 (1)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD8, FoxP3, PD-1, PD-L1 (2)

CD8, FoxP3, PD-1, PD-L1 (2)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD8, FoxP3, PD-1, PD-L1 (3)

CD8, FoxP3, PD-1, PD-L1 (3)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD8, CD68, PD-1, PD-L1 (1)

CD8, CD68, PD-1, PD-L1 (1)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD8, CD68, PD-1, PD-L1 (2)

CD8, CD68, PD-1, PD-L1 (2)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD8, CD68, PD-1, PD-L1 (3)

CD8, CD68, PD-1, PD-L1 (3)

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD4, CD8, CD68, FoxP3

CD4, CD8, CD68, FoxP3

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD4, CD8, FoxP3, Tbet

CD4, CD8, FoxP3, Tbet

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: Ki67, CD8, CD4, CD31 5x

Ki67, CD8, CD4, CD31 5x

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: Ki67, CD8, CD4, CD31 20x

Ki67, CD8, CD4, CD31 20x

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer: CD3, PD-1, PD-L1

CD3, PD-1, PD-L1

Triple-Negative Breast Cancer

Cell IDx is a Registered Supplier on and

© 2016–22 Cell IDx. Cell IDx, UltraPlex, UltraPolymer, UltraTag, and Path IDx are trademarks of Cell IDx, Inc. All Rights Reserved. Privacy Policy | Terms of Service Website by Fifth Street Design.

Your cart

Total

USD

Shipping and discount codes are added at checkout.